[1]
Dhongdi, S.R. and Siddiqui, R.A. 2020. Polypharmacy and cost analysis in patients suffering from type 2 diabetes mellitus with associated comorbidities. International Journal of Basic & Clinical Pharmacology. 9, 6 (May 2020), 929–933. DOI:https://doi.org/10.18203/2319-2003.ijbcp20202184.